Title
Language and motor function thresholds during pediatric extra-operative electrical cortical stimulation brain mapping
Date Issued
01 October 2017
Access level
metadata only access
Resource Type
research article
Author(s)
Aungaroon G.
Horn P.S.
Byars A.W.
Greiner H.M.
Tenney J.R.
Arthur T.M.
Crone N.E.
Holland K.D.
Mangano F.T.
Arya R.
Centro Médico del Hospital Infantil de Cincinnati
Publisher(s)
Elsevier Ireland Ltd.
Abstract
Objective To examine current thresholds and their determinants for language and motor mapping with extra-operative electrical cortical stimulation (ECS). Methods ECS electrocorticograph recordings were reviewed to determine functional thresholds. Predictors of functional thresholds were found with multivariable analyses. Results In 122 patients (age 11.9 ± 5.4 years), average minimum, frontal, and temporal language thresholds were 7.4 (± 3.0), 7.8 (± 3.0), and 7.4 (± 3.1) mA respectively. Average minimum, face, upper and lower extremity motor thresholds were 5.4 (± 2.8), 6.1 (± 2.8), 4.9 (± 2.3), and 5.3 (± 3.3) mA respectively. Functional and after-discharge (AD)/seizure thresholds were significantly related. Minimum, frontal, and temporal language thresholds were higher than AD thresholds at all ages. Minimum motor threshold was higher than minimum AD threshold up to 8.0 years of age, face motor threshold was higher than frontal AD threshold up to 11.8 years age, and lower subsequently. UE motor thresholds remained below frontal AD thresholds throughout the age range. Conclusions Functional thresholds are frequently above AD thresholds in younger children. Significance These findings raise concerns about safety and neurophysiologic validity of ECS mapping. Functional and AD/seizure thresholds relationships suggest individual differences in cortical excitability which cannot be explained by clinical variables.
Start page
2087
End page
2093
Volume
128
Issue
10
Language
English
OCDE Knowledge area
Pediatría
Scopus EID
2-s2.0-85026402035
PubMed ID
Source
Clinical Neurophysiology
ISSN of the container
1388-2457
Sponsor(s)
RA receives research support from Pediatric Epilepsy Research Foundation (Co-I). KDH receives funding from the following NIH Grants: R01 NS062756 (PI), R01 NS062806 (Co-I), and R01 NS065020 (Co-I). Other co-authors do not have any pertinent disclosures.
Sources of information: Directorio de Producción Científica Scopus